HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

Emerging small and medium-sized biotechs often face familiar constraints, with many hindered by the limited availability of resources. Consequently, they frequently lack the in-house capacity and breadth of expertise required to optimally navigate the transition from preclinical and clinical development to commercial success. Nonetheless, the pressure to quickly demonstrate value and progress remains unchanged, particularly in the face of growing uncertainty in the biotech landscape. As a result, it is increasingly evident that traditional consulting models are inadequate and limited in their ability to support client needs in continuously evolving and complex global markets.
This content was provided by Genesis Research Group
Company Details
Latest Content from Genesis Research Group
Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar ‘Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to…
International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research has announced the appointment of Jennifer Fillman as its new Chief Financial Officer. Prior to joining…
Genesis Research is delighted to announce a strategic partnership with Syapse®, combining the expertise and resources of both companies to better serve clients that are developing new oncology innovations.
International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes…
Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),…
GHO Capital Partners LLP, the European specialist investor in global healthcare, announces the acquisition of Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes…
